Core Viewpoint - The article emphasizes the distinction between "health products" and "health food," highlighting the prevalence of false advertising and misleading claims in the health product market in China [1][2]. Group 1: Definition and Issues - "Health products" are broadly defined without clear legal boundaries, often including items like "health wine," "height-increasing powder," and various daily consumer goods that claim health benefits, while "health food" is legally registered and can claim specific health functions [1]. - The health product market has seen significant issues such as false advertising, exaggerated claims, and consumer deception, necessitating consumer awareness in selecting legitimate health food products [1]. Group 2: Marketing Malpractices - The marketing chaos in the health product sector includes three main issues: the shift of illegal marketing to online platforms, the emergence of covert marketing channels through private live streaming, and the use of deceptive marketing tactics targeting vulnerable populations, particularly the elderly [2]. - Influencers and well-known bloggers are exploiting their reach to promote ordinary products and health foods through misleading claims, which infringes on consumer rights [2]. Group 3: Regulatory Actions - The market regulatory authority has been actively combating illegal practices since 2020, with over 6,304 cases investigated and fines totaling 260 million yuan, focusing on false advertising and unfair competition in the health product market [3]. - New initiatives include encouraging consumers to report illegal activities and enhancing supervision of direct sales companies to prevent violations [3]. Group 4: Future Directions and Consumer Guidance - The regulatory body plans to continue addressing false advertising in health products, particularly for the elderly, to protect consumer rights and maintain fair market competition [4]. - Consumers are advised to recognize legitimate health food labels, choose reputable purchasing channels, and remain vigilant against deceptive marketing tactics [4].

Core Viewpoint - The distinction between "health products" and "health food" is significant, with the former lacking clear legal definitions and often associated with misleading claims, while the latter is legally registered and can claim specific health benefits [1][2]. Group 1: Definition and Distinction - "Health products" encompass a wide range of items without clear legal definitions, including those claiming specific health benefits like "health wine" and "weight loss coffee" [1]. - "Health food" is a legally defined category under China's food safety law, allowing for specific health claims, while other foods cannot make such claims [1]. Group 2: Consumer Guidance - Consumers should recognize the health food label (commonly known as "small blue hat") and approval number, and choose products based on their health functions and target groups [2]. - It is advised to purchase health food from legitimate online and offline channels, retaining invoices or sales receipts, and to be cautious of purchases through social media or live streams [2]. - Consumers are encouraged to enhance their risk awareness and self-protection, being vigilant against false marketing tactics that suggest health benefits or treatments for diseases [2]. - Consumers should maintain their legal rights, reporting quality issues or fraudulent claims to the appropriate authorities [2].

Financial Performance - In the first half of 2025, the company achieved revenue of 3.658 billion CNY, a year-on-year increase of 4.77% [2] - Net profit attributable to shareholders reached 215 million CNY, representing a significant year-on-year growth of 115.33% [2] - Revenue from plant extraction products amounted to 1.733 billion CNY, with a year-on-year increase of 9.47% and a gross margin of 20.24%, up by 3.43% [2] Product Performance - Sales of the main product, chili red pigment, reached 6,367 tons, a year-on-year increase of 43% [3] - Chili extract sales grew to 1,536 tons, marking an 81% increase [3] - Lutein sales remained stable while promoting high-value products, with a focus on application-specific products [3] - Revenue from stevia glycosides exceeded 160 million CNY, driven by innovative processes [4] Business Strategy - The company adopted a "locking" strategy for cottonseed business to mitigate price volatility, achieving revenue of 1.765 billion CNY, a 2% increase [4] - The company plans to enhance market share for chili extract without immediate price increases, focusing on extending the processing chain [5] - The company aims to develop stevia and other tiered products into new major products, indicating significant growth potential [6] Research and Development - R&D expenses increased significantly due to changes in project structure and material costs, reflecting the company's commitment to innovation [9] - The company will continue to invest heavily in R&D while balancing costs and profits to ensure sustainable growth [9] Market Expansion - The company plans to expand its marigold planting in Myanmar, aiming to establish it as a key raw material source for lutein [7] - The company is enhancing its raw material supply chain by supporting suppliers and stabilizing market supply [8]

Group 1 - The event held on August 19 aimed to promote health food and special medical food projects, resulting in the signing of strategic cooperation agreements with seven leading companies from various countries and regions [2][3] - The conference highlighted the advantages of the Boao Lecheng International Medical Tourism Pilot Zone and its development blueprint for a "medical + exhibition + tourism" industry cluster [2] - Nearly 500 innovative health food and special medical food products were showcased during the event, covering areas such as precise nutritional supplements and functional food ingredient innovation [2] Group 2 - The signing companies aim to leverage Lecheng's policy advantages to introduce products like pain relief treatments and antibiotic ointments enhanced with stem cell technology into the Chinese market [3] - Since the implementation of health food and special medical food policies in the Lecheng Pilot Zone, eight products have been launched, including five Swiss products represented by one of the signing companies [3] - The Lecheng management will continue to enhance reform and innovation to ensure international resources are effectively utilized, enriching the supply of innovative health products [3]

东宝生物（300239）公告，公司"倍优免牌骨胶原蛋白维生素C粉"产品于近日完成国产保健食品注册工 作，并获得国家市场监督管理总局发放的国产保健食品注册证书。该产品具有有助于增强免疫力的保健 功能，注册号为国食健注G20250138，有效期至2030年4月29日。 ...